Delivery Order SPE2DB20D3101-SPE2DB25FQVK9

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3501|SPE2DB24FTZ80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which has a ceiling value of $1,804.20, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract is a Firm Fixed Price Delivery Order with a completion date of January 2, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FP4M2, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract, valued at $2,511.99, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract has a completion date of July 9, 2024 and is structured as a Firm Fixed Price Delivery Order. The prime contractor, AmerisourceBergen Drug Corp, is a major pharmaceutical...
This federal contract award, with a ceiling value of $3,051.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used for the treatment of opioid overdose. The contract has an ultimate completion date of January 9, 2024 and was awarded on January 8, 2024. It is a delivery order contract with a firm fixed...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $8,529.87 and is a Firm Fixed Price Delivery Order that runs through December 16, 2024. The contract does not have a set-aside designation, indicating it was...
This federal contract award, identified as SPE2DB20D3103|SPE2DB25FN0F9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $33,313.51 and is a Firm Fixed Price Delivery Order, with a completion date of March 12, 2025. Amerisourcebergen...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMEHQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,291.92 Firm Fixed Price Delivery Order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used for opioid overdose reversal. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. It is not...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used for the treatment of opioid overdose. The contract has a ceiling value of $1,497.79 and a completion date of April 17, 2023. This contract is not designated as a set-aside and was awarded as a firm fixed-price Delivery Order....
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMELR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The award has a ceiling value of $1,463.23 and is a Firm Fixed Price Delivery Order type contract, with a completion date of December 19, 2024. This contract is...
This federal contract award, valued at $1,127.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of July 25, 2024. This award is not designated as a set-aside...
This federal contract award, valued at $2,555.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product used in the treatment of opioid overdoses. The contract is a Firm Fixed Price Delivery Order with a completion date of February 21, 2023. The contract is not designated as a set-aside. Amerisourcebergen...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FQVK9
    Delivery Order

This federal contract award, with an ID of SPE2DB20D3101|SPE2DB25FQVK9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose.

The contract has a ceiling value of $2,673.48 and is a Firm Fixed Price Delivery Order, running from November 22, 2024 to November 25, 2024. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) and holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for the provision of a broad range of pharmaceutical products and medical supplies to support federal healthcare programs.

Generated 5/20/25, 1:44 PM